The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Mashin V.V.

Belova L.A.

Ul'ianovskiĭ gosudarstvennyĭ universitet

Dudikov E.M.

Ulyanovsk State University, Ulyanovsk, Russia

Bergelson T.M.

The Ulyanovsk State University, Ulyanovsk, Russia

Lankov V.A.

Ulyanovsk State University, Ulyanovsk, Russia

Zakuraeva K.A.

Ulyanovsk State University, Ulyanovsk, Russia

The efficacy of recognan in the early stage of ischemic stroke

Authors:

Mashin V.V., Belova L.A., Dudikov E.M., Bergelson T.M., Lankov V.A., Zakuraeva K.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(10): 44‑48

DOI: 10.17116/jnevro201711710144-48

Views: 3024

Downloaded: 44

Download PDF (RU)
Contact the author
Table of contents

THE EFFICACY OF RECOGNAN IN THE EARLY STAGE OF ISCHEMIC STROKE
THE EFFICACY OF RECOGNAN IN THE EARLY STAGE OF ISCHEMIC STROKE

To cite this article:

Mashin VV, Belova LA, Dudikov EM, Bergelson TM, Lankov VA, Zakuraeva KA. The efficacy of recognan in the early stage of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(10):44‑48. (In Russ.)
https://doi.org/10.17116/jnevro201711710144-48

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Close metadata
Recommended articles:
Cognitive impairment in post-traumatic stress diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):69-74
Features of cognitive impairment in bipo­lar affe­ctive diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):15-19
Reco­gnan (citicoline) in the correction of asthenic and anxiety-depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):43-47
Cognitive impairments and emotional diso­rders and their correction in peri­menopausal women. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):48-53
Inte­grative asse­ssment of the effe­ctiveness and safety of outpatient use of Pica­milon. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):119-130
Indi­cators of cognitive impairment of varying seve­rity in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8-2):14-20
Possibilities of mirror therapy in cognitive reha­bilitation after stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8-2):64-71
Impact of restricted physical acti­vity on pain inte­nsity and functional impairment in patients with dege­nerative spinal diso­rders. Russian Journal of Pain. 2024;(2):36-40
Como­rbid diso­rders and risk factors for neiropathic pain in distal diabetic poly­neuropathy. Russian Journal of Pain. 2024;(2):41-48
Asso­ciation between previous appe­ndectomy and cognitive impairment in adults: a case-control study. Piro­gov Russian Journal of Surgery. 2024;(7):73-77

Objective. To assess the efficacy and safety of recognan in patients with acute ischemic stroke (IS). Material and methods. Seventy-nine patients, aged from 30 to 80 years, were examined in the early stage of IS. All patients received recognan (citicoline) in dose of 1000 mg/daily during 15 days. The recovery of cognitive functions (MMSE), level of consciousness (Glasgow Coma Scale), severity of focal neurological deficit (NIHSS) and functional recovery (Rankin scale, Barthel index, Rivermead Mobility Index) were assessed. Results and conclusion. A decrease of cognitive impairment, improvement of memory, regression of neurological symptoms and increase in the motor activity were observed. Recognan used in dose of 1000 mg/daily during 15 days in the complex treatment of patients with IS promotes the recovery of cognitive function, reduces neurological symptoms and improves the recovery of motor activity.

Keywords:

recognan
citicoline
cognitive impairment
acute ischemic stroke
motor activity

Authors:

Mashin V.V.

Belova L.A.

Ul'ianovskiĭ gosudarstvennyĭ universitet

Dudikov E.M.

Ulyanovsk State University, Ulyanovsk, Russia

Bergelson T.M.

The Ulyanovsk State University, Ulyanovsk, Russia

Lankov V.A.

Ulyanovsk State University, Ulyanovsk, Russia

Zakuraeva K.A.

Ulyanovsk State University, Ulyanovsk, Russia

List of references:

  1. Suslina ZA, Fonyakin AV, Geraskina LA, Mashin VV i dr. Prakticheskaya kardionevrologiya. Pod red. Suslinoi Z.A., Fonyakina A.V. M: IMA-PRESS; 2010. (In Russ.)
  2. Belova LA, Mashin VV, Saprigina LV, Kravchenko MA, Gnedovskaya EV, Oshepkova EV, Varakin YuYa, Suslina ZA. Struktura zerebrovaskulyarnoi patologii v otkritoy populyazii pabotosposobnogo naseleniya g. Ulyanovska. Annali klinicheskoi i experimentalnoi nevrologii. 2014;4(8):4-8. (In Russ.)
  3. Reis C, Akyol O, Ho WM, Araujo C, Huang L, Applegate RII, Zhang JH. Phase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research. Biomed Res Int. 2017; 2017:4863079.
  4. Lee BK, Jung YS. Sustained Intracellular Acidosis Triggers the Na+/H+ Exchager-1 Activation in Glutamate Excitotoxicity. Biomol Ther (Seoul). 2017 Jun 14. https://doi.org/10.4062/biomolther.2017.018
  5. Lloyd-Evans E. Acidic Ca2+ stores in neurodegeneration. Messenger (Los Angel). 2016;5(1-2):37-55. https://doi.org/10.1166/msr.2016.1054.
  6. Cisneros-Mejorado A, Gottlieb M, Ruiz A, Chara JC. Blockade and knock-out of CALHM1 channels attenuate ischemic brain damage. J Cereb Blood Flow Metab. 2017:271678X17713587. https://doi.org/10.1177/0271678X17713587
  7. Michael S. Ritsner. Brain Protection in Schizophrenia, Mood and Cognitive Disorders. Springer. 2010;663. https://doi.org/10.1007/978-90-481-8553-5
  8. Secades JJ Citicoline: pharmacological and clinical review, 2016 update. Rev Neurol. 2016;63(03):1-73.
  9. Belova LA, Mashin VV, Abramova VV, Proshin AN, Ovsyannikova AN. Effectivnost Korteksina v ostrom i vosstanovitelnom periodakh polusharnogo insulta. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2016;116:10:38-42. (In Russ.)
  10. Belova LA, Mashin VV, Abramova VV, Proshin AN, Ovsyannikova AN. Dinamika kognitivnikh narusheniy u bolynikh s polusharnym ishemicheskim insultom v ostrom i rannem vosstanovitelnom periodakh na fone niskodoznoi neiroprotekzii preparatom Korteksin. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova (Insult). 2016;116:8(2):40-43. (In Russ.)
  11. Secades JJ, Alvarez-Sabín J, Castillo J, Díez-Tejedor E, Martínez-Vila E, Ríos J, Oudovenko N. Citicoline for Acute Ischemic Stroke: A Systematic Review and Formal Meta-analysis of Randomized, Double-Blind, and Placebo-Controlled Trials. J Stroke Cerebrovasc Dis. 2016;25(8):1984-1996. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.04.010
  12. Karsy M1, Brock A1, Guan J1, Taussky P1 Neuroprotective strategies and the underlying molecular basis of cerebrovascular stroke. Neurosurg Focus. 2017;42(4):3. https://doi.org/10.3171/2017.1.FOCUS16522
  13. Yuliani S, Widyarini S, Mustofa, Partadiredja G Turmeric extract inhibits apoptosis of hippocampal neurons of trimethyltin-exposed rats. Bratisl Lek Listy. 2017;118(3):142-148. https://doi.org/10.4149/BLL_2017_028
  14. Secades JJ1, Alvarez-Sabín J2, Castillo J3 Citicoline for Acute Ischemic Stroke: A Systematic Review and Formal Meta-analysis of Rand omized, Double-Blind, and Placebo-Controlled Trials. J Stroke Cerebrovasc Dis. 2016;25(8):1984-1996. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.04.010

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.